Related Experiment Video
Updated: Jun 16, 2026

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
Published on: December 17, 2021
Emerging approaches to the treatment of uveitis: patents of 2000 - 2004
1Department of Clinical Ophthalmology, Institute of Ophthalmology, Moorfields Eye Hospital, London, UK. deric@uku.co.uk
Abstract:
The treatment of non-infectious uveitis is often a challenging experience for both the patient and the treating physician. The use of traditional forms of treatment is restricted by limited effectiveness and considerable side effects. This review examines the current trends in therapy and the emerging new classes of therapeutic agents used in the treatment of non-infectious uveitis. It then examines some of the newer approaches apparent from recent patenting over the past four years and assesses their likely future significance.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Ophthalmic Drug Delivery Systems
